Dhaka, June 09, 2019: Fahmid Wasik Ali, FCMA has been appointed as the new Country Chief Financial Officer of Novartis (Bangladesh) Limited, a leading multinational pharmaceuticals of the country, effective from 1st June 2019. Fahmid will also act as the Finance Director and Company Secretary in the board of Directors of Novartis (Bangladesh) Limited.
Fahmid joined Novartis (Bangladesh) Limited in September 2006, serving most recently as the Chief Financial Officer, Pharmaceuticals Division of the Company. Fahmid held several positions of increasing responsibilities in Finance in different capacities with diverse team as an identified talent. He contributed extensively in different projects in Switzerland, India, and Singapore along with a long-term assignment in Indonesia. He brings more than 16 years of experience of which more than 13 years is in pharmaceutical industry. Fahmid holds a Post-graduation in Accounting with excellent scholastic record from University of Dhaka. He is a fellow member of The Institute of Cost and Management Accountants of Bangladesh (ICMAB). Fahmid is blessed with one son and one daughter.
About Novartis (Bangladesh) Ltd. Novartis (Bangladesh) Limited operates as a subsidiary of Novartis AG, a global healthcare company based in Switzerland that provides solutions to address the evolving needs of patients worldwide. Novartis (Bangladesh) Limited is a joint venture between Novartis AG (60%) and Bangladesh Chemical Industries Corporation (40%) of Government of People's Republic of Bangladesh. The company provides healthcare solutions specializing in research, development, manufacturing and marketing of a range of healthcare products led by pharmaceuticals. Novartis operates businesses with global scale and strong customer ties, focusing on innovative patented medicines, generics and eye care devices. The Company exports its products to more than 55 countries in Europe, Asia, Africa and Latin America.